Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hemogenyx Pharmaceuticals Plc. (OP:HOPHF)

2.330 UNCHANGED
Last Price Updated: 12:20 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hemogenyx Pharmaceuticals Plc.

< Previous 1 2 3 Next >
Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender
Via ACCESS Newswire
Hemogenyx raises £570,000 and Director's Dealing
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing
Via ACCESS Newswire
Hemogenyx Awarded Grant
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.